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Strains of influenza A have been propagated in fertile eggs (1), in 
membranes from fertile eggs (2), and in a variety of primary cell 
cultures, including chick embryo fibroblasts (3) and hamster kidney 
cells (4). The virus has been grown in established cell lines: several 
strains of influenza A were propagated in the slow-growing 1-5C-4 line 
of Chang's conjunetival cells (5, 6), and a strain of influenza A2 repli- 
cated to a low titer in KB cells (7). 
Our interest in certain biochemical aspects of influenza virus prompted 
us to search for a cell host which would grow rapidly and support virus 
multiplication to high infectivity titers in a fluid as nearly chemically 
defined as possible. 
The WSN strain of influenza A (3), which forms plaques on mono- 
layers of chicken embryo fibroblast (CEF) and 1-5C-4 cells, was serially 
passaged in three hosts. After several passages the virus was given a 
designation indicating its particular host: 
WSNE virus was grown in 10-day old embryonated eggs using 0.005 
to 0.1 hemagglutinating units of diluted allantoic fluid as inoculum and 
incubating 40 hours at 37 ~ C. Hemagglutination (HA) titrations were 
performed as previously described (8). 
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The WSNc series was initiated from WSNE by serial passage in 
primary CEF monolayers. CEF secondaries were used for plaque assay. 
Primary and secondary CEF cultures were prepared and maintained 
with supplemented medium 199 in the manner described by Levinson (9) 
except hat the fhfid and agar overlays which maintained the cells after 
infection were modified by omitting serum and adding bovine serum 
albumin to a concentration of 1 mg./m]. The other procedures for prop- 
agation and assay of WSNc were similar to those reported by Simpson 
and Hirst (3). 
The WSNH series was initiated from WSNc by serial passage in an 
established line of baby hamster kidney cells, BHK21 (10). 
Stock cultures of several established lines, BI-IK21, L (mouse), KB 
(human carcinoma), HeLa (human carcinoma) and A~ (human amnion, 
ref. 11), were grown in Eagle's minimal essential medium (MEM) containing 
100 units/ml, sodium penicillin G and 100rag./1. streptomycin sulfate 
and supplemented with 0.1 volume of fetal bovine serum. All cultures 
were incubated at 37 ~ C in an humidified atmosphere of 5% CO 2 in air. 
Cultures for virus propagation or plaque assay were prepared with 
the growth medium in 60 mm. plastic Petri plates 24 hours prior to 
infection. The confluent monolayers, containing about 5 • 106 cells, were 
washed once with Dulbeeco's phosphate buffered saline (PBS) and chal- 
lenged with 0.2 ml. of virus dilated in PBS. Adsorption was at room tem- 
perature for 30 minutes (3). 
The medium for maintenance of the cells after virus infection was 
MEM containing antibiotics, 1 mg./ml. BSA, and an increased amount 
of glucose (2 mg./ml.). Cultures for virus production received 5 ml. of 
maintenance medium, and the fluid was harvested after 48 hours incuba- 
tion. Aliquots were stored at either --20 ~ or +4 ~ C. 
Agar overlay contained 8 mg./ml, agar (Difco noble) and 30 #g./ml. 
DEAE-dextran (Pharmacia) in maintenance medium. Cultures for plaque 
assay were overlaid with 2.5 ml. of agar medinm which was permitted 
to gel for 15 minutes before the addition of 2.5 ml. of fluid maintenance 
medium. After 48 hours incubation the cell sheet was stained with 0.1 rag./ 
ml. neutral red in a modified EarIe's balanced salt solution. 
Under our conditions WSNE multiplied in eggs to I-IA titers of 128 
to 1024 and in CEF primary cultures to titers of 64 to 256, but it failed 
to produce either detectable HA or plaques in cultures of secondary 
CEF, HeLa, L or BHK21 cells. 
In the WSNc series the HA titers were low and plaque assays were 
negative during the first few passages, but the virus product of passage 6
(WSNc6) regained the HA titer of 256 which had been obtained after 
the initial infection with WSNm WSNc6 produced plaques on CEF 
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secondary monolayers, but the plating efficiency was low and erratic. 
Several modifications of the overlay did not improve the results. WSNc 5, 
7, and 9 failed to produce detectable HA or plaques on monolayers of 
HeLa or L cells. 
WSNc 11 was inoculated onto monolayers of BHK21,  L, KB, HeLa, 
and A s cells to test for incomplete cycles of replication. The cultures 
were examined for hemadsorbing centers (12) using chicken erythrocytes 
and hemoglobin stain (13). Hemadsorbing loci, though clearly visible 
Table 1. Representat ive  Ser ia l  Passages  of WSNH in BHK21 Cells 
Ex  o 
periment 
Passage 
numb er 
1 
2 
3 
4 
5 
6 
8 
11 
14 
17 
Inocttlum 
HA units 
WSNc14; 0.05 
WSNH1; 26** 
W S~N~H2; 0.4 
WSNH3; 0.05 
WS~Hd; 0.025 
WSNH5 ; 0.003 
WSNH7; 0.025 
WSNH10; 0.17 
WSNH13; 0.005 
WS~H16; 0.0025 
Characteristics of product* 
Log (HA/ml.) I Log (PFU/ml.) Log (PFU/H/~) 
7.4 
7.5 
8.6 
8.3 
8.6 
8.5 
8.3 
8.2 
8.4 
8.5 
6.2 
5.7 
5.9 
5.9 
6.2 
6.4 
6.5 
6.1 
6.4 
6.5 
WSNcI6;  0.025 
WSNH 1; 0.0013 
WSNH 2; 0.0025 
WSNH 3; 0.0025 
2.1 
0.3 
2.4 
2.1 
1.2 
1.8 
2.7 
2.4 
2.4 
2.1 
1.8 
2.1 
2.0 
2.0 
* The fluid overlay was harvested 72 hours after infection for passages 1and 2 
of experiment 1 and 48 hours after infection for the other passages. 
** Smaller inocula of WSNH1 produced no detectable HA. 
on infected plates of all the cell lines, were far more numerous on BHK21 
cells. WSNc 12 gave similar results. 
The five cell lines were tested for virus production with WSNc 14, 
and the following HA titers were obtained: BHK21-128;  L-32; KB-16; 
HeLa-4; and A~-16. The BHK21 cells were therefore selected for further 
studies. These cells increased ten-fold in 48 hours after transfer, and the 
cell sheet could be maintained in good condition for 72 hours after virus 
infection. 
The virus progeny from the BHK21 cells were serially passaged in 
BHK21 cells to initiate the WSNH series. A partial record of this series 
is shown in Table 1, Experiment 1: A second and similar series, initiated 
with WSNc l6 ,  is recorded in Table 1, Experiment 2. WSNH forms 
small, regular, clear plaques on BHK21 monolayers. Some plaques, after 
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staining with neutral red, have red borders similar to those observed in 
1-5C-4 cell cultures infected with the CAM influenza strain (6). 
Several properties of WSN~, WSNc, and WSNH were compared : 
1. The three viruses and polyvalent influenza vaccine, all at 16 HA 
units/ml., were compared by the HA inhibition test. The vaccine served 
to test antiserum specificity. The highest dilutions of anti-WSN serum 
producing iiflaibition of HA were: 1 : 640-690 for WSNE ; 1 : 640 for WSNc 
and WSN~ ; and 1 : 80 for polyvalent vaccine. 
2. The I-IA titers of the three viruses were from two- to four-fold 
lower when sheep erythrocytes were substituted for chicken erythrocytes. 
3. WSNE and WSN~ were compared for egg 50~/o infections dose 
(]~IDh0) by standard techniques (14, 15). The log (EIDh0/ItA) for WSNE 
was 6.5 and for WSNH9 was 5.8. 
4. The infectivities of WSNc I6  and WSN~15 were measured in 
plaque forming units (PFU) on BItK21 monolayers. The log (PFU/HA) 
for WSNc 16 was 5.3 and for WSNnl5  was 6.1. 
5. Examination by electron microscopy showed that the three viruses 
have similar morphologies (I6). 
These results indicate that WSNr., WSNc, an4 WSNH are closely 
related, but not identical viruses. 
The two most distinguishing properties of the WSNH-BI-IK21 system 
are the rapid growth rate of BHK21 cells and the high specific infectivity 
of WSNH virus. The PFU/EIDh0 ratio for WSN~ is greater than one, but 
that ratio is less than one for other inflnenza virus systems using either 
primary (3, 4) or established (6) cell hosts. The Pt~U/HA ratio for WSNH 
and the EIDso/HA ratios of egg-adapted strains are of the same mag- 
nitude. We believe that virus from the WSN~ series differs sufficiently 
from the WSN strain with which this investigation was initiated to warrant 
the separate designation WSNH. Studies are in progress on the nucleic 
acid of WSNH and the nucleic acids produced upon infection. 
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